Rusyn I, Greene N . 2018. The impact of novel assessment methodologies in toxicology on green chemistry and chemical alternatives. Toxicol Sci 161(2):276-284; doi: 10.1093/toxsci/kfx196 . PMID: 29378069.
View Abstract
Topics: NAMs
Roberts DW, Patlewicz G . 2018. Non-animal assessment of skin sensitization hazard – Is an integrated testing strategy needed, and if so what should be integrated? J Appl Toxicol 38(1):41-50; doi: 10.1002/jat.3479 . PMID: 28543848.
View Abstract
Topics: Adverse outcome pathways (AOPs) , modeling
2017 (62 POSTS)
Thompson CM , Wolf, JC, McCoy A, Suh M , Proctor DM , Kirman CR, Haws LC , Harris MA. 2017. Comparison of toxicity and recovery in the duodenum of B6C3F1 mice following treatment with intestinal carcinogens captan, folpet, and hexavalent chromium. Toxicol Pathol 45(8):1091–1101; doi: 10.1177/019262331yy4324 . PMID: 29161989.
View Abstract
Topics: carcinogens , chromium
Sanz F, Pognan F, Steger-Hartmann T, Díaz C, Cases M, Pastor M, Marc P,…, Greene N , et al. 2017. Legacy data sharing to improve drug safety assessment: The eTOX project. Nat Rev Drug Discov 6(12):811-812; doi: 10.1038/nrd.2017.177 . PMID: 29026211.
View Abstract
Topics: drug development , safety assessment
Schaefer HR , Myers, JL. 2017. Guidelines for performing systematic reviews in the development of toxicity factors. Regul Toxicol Pharmacol 91(Dec):124-141; doi: 10.1016/j.yrtph.2017.10.008 . PMID: 29080853.
View Abstract
Topics: risk assessment , Systematic Review
Wheeler MW , Dunson DB, Herring AH. 2017. Bayesian local extremum splines. Biometrika 104(4):939-52; doi: 10.1093/biomet/asx039 . PMID: 29422695.
View Abstract
Topics: Bayesian modeling
Stephenson CJ, Rossheim ME, Frankenfeld CL , Boncy J, Okech BO, von Fricken ME. 2017. Cross-sectional analysis of the association between bedtime and malaria exposure in the Ouest and Sud-Est Departments of Haiti. Acta Tropica 176(Dec):188–19; doi: 10.1016/j.actatropica.2017.08.011 . PMID: 28818627.
View Abstract
Topics: malaria
Lansita J, Mease KM , Qiu H, Yednock T, Sankaranarayanan S, Kramer S. 2017. Nonclinical development of ANX005: A humanized anti-Clq antibody for treatment of autoimmune and neurodegenerative diseases. Int J Toxicol 36(6)449-462; doi: 10.1177/1091581817740873 . PMID: 29202623.
View Abstract